First Trust NYSE Arca Biotechnology Index Fund(FBT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

FBT First Trust NYSE Arca Biotechnology Index Fund

Market Closed 10-23 16:00:00 EDT

269.25

-3.43

-1.26%

盘后269.25

+0.000.00%

19:30 EDT

High271.54	Low268.02	Vol60.23K
Open271.54	D1 Closing272.68	Amplitude1.29%
Mkt Cap2.95B	Tradable Cap2.95B	Total Shares10.95M
T/O16.24M	T/O Rate0.55%	Tradable Shares10.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":269.25,"timestamp":1792785600000,"preClose":272.68,"halted":0,"volume":60227,"hourTrading":{"tag":"盘后","latestPrice":269.25,"preClose":269.25,"latestTime":"19:30 EDT","volume":51,"amount":13620.6901,"timestamp":1792798204183,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012578847000146717,"floatShares":10950002,"shares":10950002,"eps":8.545272,"marketStatus":"Market Closed","change":-3.43,"latestTime":"10-23 16:00:00 EDT","open":271.54,"high":271.54,"low":268.02,"amount":16244860.074399998,"amplitude":0.012909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":272.68,"sharesOutstanding":11450002,"nav":272.54,"aum":2995630544.66,"bidAskSpread":0.00105,"preHourTrading":{"tag":"盘前","latestPrice":272.68,"preClose":272.68,"latestTime":"04:00 EDT","volume":1,"amount":272.68,"timestamp":1792742417416,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":269.25,"preClose":269.25,"latestTime":"19:30 EDT","volume":51,"amount":13620.6901,"timestamp":1792798204183,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0592230698695275,"impliedVol":0.2485,"impliedVolPercentile":0.9124},"requestUrl":"/m/hq/s/FBT/wiki","defaultTab":"wiki","newsList":[{"id":"2677974368","title":"Corcept Therapeutics Down over 17%, on Pace for Largest Percent Decrease Since December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2677974368","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677974368?lang=en_us&edition=fundamental","pubTime":"2026-10-24 02:40","pubTimestamp":1792780800,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics Incorporated.  is currently at $88.51, down $18.99 or 17.66%--Would be lowest close since July 13, 2026, when it closed at $85.90--On pace for largest percent decrease since Dec. 31, 2025, when it fell 50.42%--Currently down three consecutive days; down 23.99% over this period--Worst three-day stretch since the three days ending Jan. 5, 2026, when it fell 50.21%--Down 19.65% this week; worst weekly performance since the week ending Jan. 2, 2026, when it fell 53.78%--Down 23.19% month-to-date; on pace for worst month since Dec. 2025, when it fell 56.17%--Up 154.35% year-to-date; on pace for best year since 2009, when it rose 172.55%--Down 28.37% from its all-time closing high of $123.57 on Aug. 25, 2026--Up 22.05% from 52 weeks ago , when it closed at $72.52--Down 28.37% from its 52-week closing high of $123.57 on Aug. 25, 2026--Up 175.31% from its 52-week closing low of $32.15 on March 13, 2026--Traded as low as $84.89; lowest intraday level since July 13, 2026, wh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","LU0566484027.USD","LU1559883803.SGD","FBT","PSCH","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677941151","title":"Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Offers Upside, According to Wall Street?","url":"https://stock-news.laohu8.com/highlight/detail?id=2677941151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677941151?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:14","pubTimestamp":1792743299,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA) and BioNTech ($BNTX) are biotech stocks focused on cancer vaccines as they enter their next growth phase. According to TipRanks Com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/moderna-mrna-vs-biontech-bntx-which-biotech-stock-offers-upside-according-to-wall-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/moderna-mrna-vs-biontech-bntx-which-biotech-stock-offers-upside-according-to-wall-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BIOY","BK4581","WDNA","LGHT","BIS","MRNX","PTH","BNTX","IBB","IDNA","BK4501","NVIB","XLK","BK4535","BK4532","BK4534","MRNA","BK4533","BK4551","BK4568","RXL","MRNY","XBIX","XBI","GNOM","BK4139","BK4548","BK4585","JHMH","FXH","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677949787","title":"Veracyte’s Decipher Test Predicts Abiraterone Benefit in Very High-Risk Prostate Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2677949787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677949787?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:00","pubTimestamp":1792742438,"startTime":"0","endTime":"0","summary":"Veracyte’s Decipher Test Predicts Abiraterone Benefit in Very High-Risk Prostate Cancer StudyVeracyte’s Decipher Prostate test predicted benefit from adding abiraterone to hormone therapy in men with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDL5fnlZz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","LU0314104364.USD","NDAQ","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","BK4585","FBT","SG9999014021.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD","VCYT","BK4139","LU2095319765.USD","SG9999014005.SGD","BCDF","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677949279","title":"Phase Iii Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2677949279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677949279?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:00","pubTimestamp":1792742400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nTUA9RFR74:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677676826","title":"October 2026's Top Insider-Owned Growth Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2677676826","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677676826?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:05","pubTimestamp":1792580730,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has remained flat, yet it is up 12% over the past year with earnings forecast to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its future potential.","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/october-2026s-top-insider-owned-growth-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nuvb/nuvation-bio/news/october-2026s-top-insider-owned-growth-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["STDN","FBT","LU1559883803.SGD","BK4007","CORT","BK4532","PSCH","BK4156","LU0566484027.USD","NUVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677616516","title":"Bruker Corporation Publishes Update to Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2677616516","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677616516?lang=en_us&edition=fundamental","pubTime":"2026-10-21 04:01","pubTimestamp":1792526491,"startTime":"0","endTime":"0","summary":"Bruker Corporation publishes update to financial calendarBruker will release third-quarter 2026 financial results before the market opens on Nov. 4, 2026.A conference call and webcast to discuss resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL3YlzK9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BRKR","LU1815336091.USD","LU0757428866.USD","TINY","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677163056","title":"Alkermes Schedules Third-Quarter Financial Results Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2677163056","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677163056?lang=en_us&edition=fundamental","pubTime":"2026-10-21 04:00","pubTimestamp":1792526420,"startTime":"0","endTime":"0","summary":"Alkermes Schedules Third-Quarter Financial Results CallAlkermes will report third-quarter financial results on Nov. 3, 2026.A conference call and webcast to discuss the results will begin that day at ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL2H1jY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","MEDX","ALKS","IBRN","PSCH","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677616344","title":"Alkermes to Report Third Quarter Financial Results on November 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677616344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677616344?lang=en_us&edition=fundamental","pubTime":"2026-10-21 04:00","pubTimestamp":1792526400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nTUAQ6XGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","ALKS","PSIL","IBRN","FBT","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677613649","title":"OpenAI confirms acquisition of biopharma platform Orchestra Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2677613649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677613649?lang=en_us&edition=fundamental","pubTime":"2026-10-21 02:10","pubTimestamp":1792519820,"startTime":"0","endTime":"0","summary":"OpenAI confirmed it has acquired Orchestra Bio, a “platform that helps biopharma teams coordinate the complex process of drug development.” OpenAI ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/openai-confirms-acquisition-of-biopharma-platform-orchestra-bio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/openai-confirms-acquisition-of-biopharma-platform-orchestra-bio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","LFSC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677613939","title":"OpenAI acquires biotech startup Orchestra Bio, Axios reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2677613939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677613939?lang=en_us&edition=fundamental","pubTime":"2026-10-21 02:05","pubTimestamp":1792519534,"startTime":"0","endTime":"0","summary":"OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/openai-acquires-biotech-startup-orchestra-bio-axios-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/openai-acquires-biotech-startup-orchestra-bio-axios-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","VTHR","XBIX","CHAT","QTOC","NVIB","AIPO","AGIQ","LNGR","ARTY","FBT","IEIH","AGIX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676068243","title":"Disc Medicine Stock (IRON) Soars Over 28% on a Phase 3 Trial Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2676068243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676068243?lang=en_us&edition=fundamental","pubTime":"2026-10-19 23:19","pubTimestamp":1792423159,"startTime":"0","endTime":"0","summary":"Disc Medicine stock gained on Monday following new clinical trial results that met primary and secondary endpoints.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/disc-medicine-stock-iron-soars-over-28-on-a-phase-3-trial-win?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/disc-medicine-stock-iron-soars-over-28-on-a-phase-3-trial-win?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","CNCR","PBPH","GNOM","FXH","PSCH","TBXU","MNTL","JHMH","MDTX","PBE","HYLG","PJP","MEDI","MRNY","PSIL","IBRN","APXH","BBH","AZNH","GNMX","IBBJ","JDOC","LLYX","SURI","BBP","BIB","CANC","IDNA","FTXH","GDOC","FHLC","PTH","IBBQ","BME","CURE","PINK","GSKH","XPH","IEIH","IRON","SYNB","LFSC","WDNA","NVIB","FBT","SBIO","RSPH","IBB","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676506685","title":"Veracyte Study Shows Decipher Test Predicts Abiraterone Benefit in Very High-Risk Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2676506685","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676506685?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:14","pubTimestamp":1792412078,"startTime":"0","endTime":"0","summary":"Veracyte Study Shows Decipher Test Predicts Abiraterone Benefit in Very High-Risk Prostate CancerVeracyte will present six genomic test studies at the ESMO Congress in Madrid, October 23-27, 2026.Deci","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nNDL1JcYyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","SG9999014013.SGD","BK4585","BK4139","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","BCDF","IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","BK4588","NDAQ","LU0314104364.USD","LU2210150020.SGD","BK4112","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","SG9999014039.USD","IE00BGHQF748.EUR","VCYT","SG9999014005.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676715683","title":"Press Release: $2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2676715683","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676715683?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:00","pubTimestamp":1792411200,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel and RALEIGH, N.C., Oct. 19, 2026 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (\"RedHill\" or the \"Company\"), a specialty biopharmaceutical company, today announced that its pa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1550","BK4202","IBBQ","TBXU","R","NCI","CAR","RDHL","BK4232","LU0264606111.USD","GNOM","CNCR","BK1584","SYNB","BK4007","BK4585","BK4230","BK4588","LU0572939691.SGD","FBT","BK4022","LU0572940350.SGD","BK1184","01336","LFSC","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676683027","title":"Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2676683027","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676683027?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:00","pubTimestamp":1792411200,"startTime":"0","endTime":"0","summary":"Oral presentations include new Decipher treatment-selection evidence and an OPTIMA breast cancer health economic analysisSOUTH SAN FRANCISCO, Calif., Oct.  19, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/19/3383396/0/en/six-studies-to-highlight-veracyte-s-genomic-tests-across-breast-prostate-and-bladder-cancer-at-esmo-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BC","BK4190","BK4139","IE00B19Z3581.USD","FBT","BK4092","IE00B19Z3B42.SGD","VCYT","PSCE","NE","IE0002270589.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676688177","title":"Analysts’ Top Healthcare Picks: Alkermes (ALKS), BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2676688177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676688177?lang=en_us&edition=fundamental","pubTime":"2026-10-19 19:20","pubTimestamp":1792408815,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and BridgeBio Pharma (BBIO) with bul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alkermes-alks-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alkermes-alks-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","LU0128526141.USD","MEDX","LU0029874061.USD","BBIO","PSIL","IBRN","BK4588","LU0889565916.HKD","LABU","ALKS","HCSG","PSCH","LU0320765992.SGD","BK4505","BK4139","BK4137","XBI","BK4581","XLV","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676501702","title":"Sensorion hires veteran gene therapy leader Peter Weber as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2676501702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676501702?lang=en_us&edition=fundamental","pubTime":"2026-10-19 17:08","pubTimestamp":1792400904,"startTime":"0","endTime":"0","summary":"Sensorion SAS ( ($FR:ALSEN) ) has provided an announcement. Sensorion has appointed Peter Weber, MD, MBA, an otologist and neurotologist with more ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sensorion-hires-veteran-gene-therapy-leader-peter-weber-as-chief-medical-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sensorion-hires-veteran-gene-therapy-leader-peter-weber-as-chief-medical-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","CNCR","BK4588","TBXU","BK4585","GNOM","FBT","IBB","LFSC","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676517843","title":"Corcept Therapeutics Director James N. Wilson Reports Sale of $1.15 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2676517843","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676517843?lang=en_us&edition=fundamental","pubTime":"2026-10-17 06:25","pubTimestamp":1792189529,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics Director James N. Wilson Reports Sale of $1.15 Million in Common SharesCorcept Therapeutics director James N. Wilson sold 10,000 common shares on Oct. 15, 2026.Sales comprised 6,6","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL1lTVTc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Therapeutics Director James N. Wilson Reports Sale of $1.15 Million in Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","LU1559883803.SGD","FBT","BK4532","PSCH","CORT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675759052","title":"Veracyte's Prosigna Breast Cancer Recurrence Test Gets Medicare Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2675759052","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675759052?lang=en_us&edition=fundamental","pubTime":"2026-10-16 21:58","pubTimestamp":1792159104,"startTime":"0","endTime":"0","summary":"Veracyte  said Friday its Prosigna test, which estimates how likely early-stage breast cancer is to come back over 10 years, received Medicare coverage through Palmetto GBA's MolDX program.Coverage has been effective since Aug. 19 and applies to postmenopausal women with early-stage estrogen receptor-positive disease at stage 1 or 2 and with up to three positive lymph nodes, the company said.The Optima phase 3 trial showed that Prosigna-guided treatment could spare more than two-thirds of clinically high-risk patients chemotherapy without worse outcomes, it added.Price: 44.26, Change: -0.13, Percent Change: -0.29","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LNGR","VCYT","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675597588","title":"Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2675597588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675597588?lang=en_us&edition=fundamental","pubTime":"2026-10-16 21:15","pubTimestamp":1792156520,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nFWN4621TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675959403","title":"Alkermes Plc : Truist Securities Reinstates Coverage with Buy Rating; Target Price $55","url":"https://stock-news.laohu8.com/highlight/detail?id=2675959403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675959403?lang=en_us&edition=fundamental","pubTime":"2026-10-16 20:33","pubTimestamp":1792153999,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nFWN4622IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","PSIL","ALKS","FBT","BK4139","PSCH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ftportfolios.com/Retail/etf/etfsummary.aspx?Ticker=FBT","stockEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.0001},{"period":"3month","weight":0.0884},{"period":"6month","weight":0.3196},{"period":"1year","weight":0.4219},{"period":"ytd","weight":0.3037}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.","yearOnYearQuotes":[{"month":1,"riseRate":0.65,"avgChangeRate":0.028931},{"month":2,"riseRate":0.4,"avgChangeRate":0.001237},{"month":3,"riseRate":0.7,"avgChangeRate":0.017863},{"month":4,"riseRate":0.5,"avgChangeRate":0.005723},{"month":5,"riseRate":0.55,"avgChangeRate":0.011684},{"month":6,"riseRate":0.7,"avgChangeRate":0.019337},{"month":7,"riseRate":0.571429,"avgChangeRate":0.033041},{"month":8,"riseRate":0.571429,"avgChangeRate":0.004744},{"month":9,"riseRate":0.52381,"avgChangeRate":-0.002619},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.01118},{"month":11,"riseRate":0.75,"avgChangeRate":0.034401},{"month":12,"riseRate":0.6,"avgChangeRate":0.010599}],"exchange":"ARCA","name":"First Trust NYSE Arca Biotechnology Index Fund","nameEN":"First Trust NYSE Arca Biotechnology Index Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"First Trust NYSE Arca Biotechnology Index Fund(FBT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest First Trust NYSE Arca Biotechnology Index Fund(FBT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"First Trust NYSE Arca Biotechnology Index Fund,FBT,First Trust NYSE Arca Biotechnology Index Fund股票,First Trust NYSE Arca Biotechnology Index Fund股票老虎,First Trust NYSE Arca Biotechnology Index Fund股票老虎国际,First Trust NYSE Arca Biotechnology Index Fund行情,First Trust NYSE Arca Biotechnology Index Fund股票行情,First Trust NYSE Arca Biotechnology Index Fund股价,First Trust NYSE Arca Biotechnology Index Fund股市,First Trust NYSE Arca Biotechnology Index Fund股票价格,First Trust NYSE Arca Biotechnology Index Fund股票交易,First Trust NYSE Arca Biotechnology Index Fund股票购买,First Trust NYSE Arca Biotechnology Index Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"First Trust NYSE Arca Biotechnology Index Fund(FBT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest First Trust NYSE Arca Biotechnology Index Fund(FBT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}